Matsukura N, Kawachi T, Sasajima K, Sano T, Sugimura T, Hirota T
J Natl Cancer Inst. 1978 Jul;61(1):141-4. doi: 10.1093/jnci/61.1.141.
N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG) was administered orally to male Wistar rats at a concentration of 83 microgram/ml in the drinking water for 2, 4, 5, and 7 months; the rats were killed at about month 15. Intestinal metaplasia was found in the stomachs of 80-100% of the rats treated with MNNG for 4 or more months, of 37.5% treated with MNNG for 2 months, and of 10% of the controls. Metaplastic glands, composed of goblet cells and columnar cells with striated borders, were found in the pyloric region. Paneth's cells were found at the bottom of metaplastic glands in a rat treated with MNNG for 4 months. The incidence of well-differentiated adenocarcinomas of the stomach was 63-90% in rats treated with MNNG for 4 or more months and 25% in those treated with MNNG for 2 months.
将N-甲基-N'-硝基-N-亚硝基胍(MNNG)以83微克/毫升的浓度加入雄性Wistar大鼠的饮用水中,分别持续灌胃2、4、5和7个月;在大约第15个月时处死大鼠。在接受MNNG处理4个月及以上的大鼠中,80%-100%的大鼠胃中出现肠化生,接受MNNG处理2个月的大鼠中,37.5%出现肠化生,而对照组中这一比例为10%。在幽门区域发现了由杯状细胞和有纹状缘的柱状细胞组成的化生腺体。在一只接受MNNG处理4个月的大鼠化生腺体底部发现了潘氏细胞。接受MNNG处理4个月及以上的大鼠中,高分化胃腺癌的发生率为63%-90%,接受MNNG处理2个月的大鼠中这一发生率为25%。